Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 16:59:43
256,40 DKK
Kurs
Kurs
0,45%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
409,95 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 25.09.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,40 225 | 256,40 | 225 | 12,24649 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.10.2026 0 Monate | 05.10.2026 | 0 Monate | 256,40 275 | 256,40 | 275 | 7,25429 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,40 245 | 256,40 | 245 | 4,446178 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,40 245 | 256,40 | 245 | 4,446178 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 22.09.2026 12 Monate | 22.09.2026 | 12 Monate | 256,40 305 | 256,40 | 305 | 18,954758 | BERENBERG | ||
| Novo Nordisk AS | 21.09.2026 12 Monate | 21.09.2026 | 12 Monate | 256,40 285 | 256,40 | 285 | 11,154446 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 256,40 275 | 256,40 | 275 | 7,25429 | JPMORGAN | ||
| Novo Nordisk AS | 21.09.2026 12 Monate | 21.09.2026 | 12 Monate | 256,40 275 | 256,40 | 275 | 7,25429 | JEFFERIES | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 256,40 260 | 256,40 | 260 | 1,404056 | JPMORGAN | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 256,40 332 | 256,40 | 332 | 29,485179 | UBS | ||
| Novo Nordisk AS | 16.09.2026 0 Monate | 16.09.2026 | 0 Monate | 256,40 332 | 256,40 | 332 | 29,485179 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,40 265 | 256,40 | 265 | 3,354134 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 11.09.2026 12 Monate | 11.09.2026 | 12 Monate | 256,40 250 | 256,40 | 250 | 2,4961 | MORGAN STANLEY | ||
| Novo Nordisk AS | 07.09.2026 12 Monate | 07.09.2026 | 12 Monate | 256,40 300 | 256,40 | 300 | 17,00468 | BARCLAYS | ||
| Novo Nordisk AS | 03.09.2026 0 Monate | 03.09.2026 | 0 Monate | 256,40 275 | 256,40 | 275 | 7,25429 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,40 265 | 256,40 | 265 | 3,354134 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,40 265 | 256,40 | 265 | 3,354134 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,40 290 | 256,40 | 290 | 13,104524 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 24.08.2026 0 Monate | 24.08.2026 | 0 Monate | 256,40 275 | 256,40 | 275 | 7,25429 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,40 290 | 256,40 | 290 | 13,104524 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.08.2026 0 Monate | 11.08.2026 | 0 Monate | 256,40 305 | 256,40 | 305 | 18,954758 | BERENBERG | ||
| Novo Nordisk AS | 07.08.2026 0 Monate | 07.08.2026 | 0 Monate | 256,40 | 256,40 | -- | DZ BANK | |||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 256,40 285 | 256,40 | 285 | 11,154446 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 256,40 290 | 256,40 | 290 | 13,104524 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 256,40 200 | 256,40 | 200 | 21,99688 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 256,40 332 | 256,40 | 332 | 29,485179 | UBS | ||
| Novo Nordisk AS | 05.08.2026 12 Monate | 05.08.2026 | 12 Monate | 256,40 310 | 256,40 | 310 | 20,904836 | BARCLAYS | ||
| Novo Nordisk AS | 04.08.2026 12 Monate | 04.08.2026 | 12 Monate | 256,40 285 | 256,40 | 285 | 11,154446 | JEFFERIES | ||
| Novo Nordisk AS | 04.08.2026 0 Monate | 04.08.2026 | 0 Monate | 256,40 332 | 256,40 | 332 | 29,485179 | UBS | ||
| Novo Nordisk AS | 31.07.2026 0 Monate | 31.07.2026 | 0 Monate | 256,40 250 | 256,40 | 250 | 2,4961 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,40 290 | 256,40 | 290 | 13,104524 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 256,40 332 | 256,40 | 332 | 29,485179 | UBS | ||
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 256,40 285 | 256,40 | 285 | 11,154446 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 256,40 250 | 256,40 | 250 | 2,4961 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,40 290 | 256,40 | 290 | 13,104524 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 256,40 325 | 256,40 | 325 | 26,75507 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,40 290 | 256,40 | 290 | 13,104524 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 256,40 250 | 256,40 | 250 | 2,4961 | JPMORGAN | ||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 256,40 250 | 256,40 | 250 | 2,4961 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 256,40 305 | 256,40 | 305 | 18,954758 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 256,40 270 | 256,40 | 270 | 5,304212 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,40 290 | 256,40 | 290 | 13,104524 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,40 290 | 256,40 | 290 | 13,104524 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 256,40 300 | 256,40 | 300 | 17,00468 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 256,40 270 | 256,40 | 270 | 5,304212 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 256,40 175 | 256,40 | 175 | 31,74727 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,40 290 | 256,40 | 290 | 13,104524 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,40 290 | 256,40 | 290 | 13,104524 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 256,40 | 256,40 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 256,40 300 | 256,40 | 300 | 17,00468 | BARCLAYS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 256,40 332 | 256,40 | 332 | 29,485179 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 256,40 250 | 256,40 | 250 | 2,4961 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 256,40 263 | 256,40 | 263 | 2,574103 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 256,40 250 | 256,40 | 250 | 2,4961 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 256,40 175 | 256,40 | 175 | 31,74727 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 256,40 300 | 256,40 | 300 | 17,00468 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 256,40 250 | 256,40 | 250 | 2,4961 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,40 275 | 256,40 | 275 | 7,25429 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 256,40 270 | 256,40 | 270 | 5,304212 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 256,40 250 | 256,40 | 250 | 2,4961 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 256,40 270 | 256,40 | 270 | 5,304212 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 256,40 332 | 256,40 | 332 | 29,485179 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 256,40 270 | 256,40 | 270 | 5,304212 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 256,40 263 | 256,40 | 263 | 2,574103 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 256,40 270 | 256,40 | 270 | 5,304212 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 256,40 250 | 256,40 | 250 | 2,4961 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 256,40 275 | 256,40 | 275 | 7,25429 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 256,40 270 | 256,40 | 270 | 5,304212 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 256,40 250 | 256,40 | 250 | 2,4961 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 256,40 270 | 256,40 | 270 | 5,304212 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 256,40 270 | 256,40 | 270 | 5,304212 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 256,40 300 | 256,40 | 300 | 17,00468 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 256,40 250 | 256,40 | 250 | 2,4961 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 256,40 270 | 256,40 | 270 | 5,304212 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 256,40 260 | 256,40 | 260 | 1,404056 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 256,40 270 | 256,40 | 270 | 5,304212 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 256,40 270 | 256,40 | 270 | 5,304212 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 256,40 400 | 256,40 | 400 | 56,00624 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 256,40 250 | 256,40 | 250 | 2,4961 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 256,40 400 | 256,40 | 400 | 56,00624 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 256,40 332 | 256,40 | 332 | 29,485179 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 256,40 340 | 256,40 | 340 | 32,605304 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 256,40 275 | 256,40 | 275 | 7,25429 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 256,40 350 | 256,40 | 350 | 36,50546 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 256,40 340 | 256,40 | 340 | 32,605304 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 256,40 275 | 256,40 | 275 | 7,25429 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 256,40 250 | 256,40 | 250 | 2,4961 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 256,40 270 | 256,40 | 270 | 5,304212 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 256,40 340 | 256,40 | 340 | 32,605304 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 256,40 340 | 256,40 | 340 | 32,605304 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 256,40 340 | 256,40 | 340 | 32,605304 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 256,40 340 | 256,40 | 340 | 32,605304 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,40 400 | 256,40 | 400 | 56,00624 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 256,40 275 | 256,40 | 275 | 7,25429 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 256,40 360 | 256,40 | 360 | 40,405616 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 256,40 360 | 256,40 | 360 | 40,405616 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 256,40 360 | 256,40 | 360 | 40,405616 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 256,40 350 | 256,40 | 350 | 36,50546 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 256,40 332 | 256,40 | 332 | 29,485179 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 256,40 475 | 256,40 | 475 | 85,25741 | DEUTSCHE BANK RESEARCH |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M